Shopping Cart
- Remove All
- Your shopping cart is currently empty
VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent. It acts by reducing mitochondrial oxidative phosphorylation in tumor cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | 45 € | In Stock | |
10 mg | 73 € | In Stock | |
25 mg | 150 € | In Stock | |
50 mg | 249 € | In Stock | |
100 mg | 427 € | In Stock |
Description | VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent. It acts by reducing mitochondrial oxidative phosphorylation in tumor cells. |
In vitro | VLX600 as a drug that is preferentially active against quiescent cells in colon cancer 3-D microtissues.?The anticancer activity is associated with reduced mitochondrial respiration, leading to bioenergetic catastrophe and tumour cell death.?VLX600 shows enhanced cytotoxic activity under conditions of nutrient starvation.?Importantly, VLX600 displays tumour growth inhibition in vivo. |
Cell Research | HCT116, HT29, SW620, HT8, DLD and RKO cells.Concentration,0.1, 1, 10, 100μM. 72 hours |
Molecular Weight | 317.35 |
Formula | C17H15N7 |
Cas No. | 327031-55-0 |
Smiles | CC(=NNc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1 |
Relative Density. | 1.42 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 8 mg/mL (25.21 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.